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Summary
 
Follicular dendritic cell networks are said to be pivotal to both the formation of germinal cen-
ters (GCs) and their functions in generating antigen-specific antibody affinity maturation and B
cell memory. We report that lymphotoxin 
 
b
 
–deficient mice form GC cell clusters in the gross
anatomical location expected of GCs, despite the complete absence of follicular dendritic cell
networks. Furthermore, antigen-specific GC generation was at first relatively normal, but these
GCs then rapidly regressed and GC-phase antibody affinity maturation was reduced. Lympho-
toxin 
 
b
 
–deficient mice also showed substantial B cell memory in their mesenteric lymph
nodes. This memory antibody response was of relatively low affinity for antigen at week 4 after
challenge, but by week 10 after challenge was comparable to wild-type, indicating that affinity
maturation had failed in the GC phase but developed later.
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ollicular dendritic cells (FDCs)
 
1
 
 are characterized by
their location within B cell follicles and their extensive
dendritic process networks, which retain antigen–Ig com-
plexes via both complement receptors and Ig Fc receptors
(for reviews, see references 1–4). Some antigen retained by
FDCs is held within convolutions of the dendritic process
network for periods of 
 
.
 
1 yr and is thought to play an im-
portant role in the maintenance of long-term B cell mem-
ory. It is perhaps these same processes that have gained
FDCs notoriety as a reservoir of HIV (5–8).
FDCs also give up some of their retained antigen much
earlier, during the germinal center (GC) reaction. GCs are
highly specialized structures that develop within primary B
cell follicles upon antigenic challenge (9, 10). Antigen-spe-
cific B cells within GCs undergo somatic hypermutation of
their antigen-binding receptor in a process of antibody af-
finity maturation (9–11). GC B cells are intimately associ-
ated with FDC dendritic processes, and antigen provided
by FDC networks is thought to be critical for the selection
of higher affinity clones within GCs and subsequent mem-
ory B cell formation (1–3, 12). FDCs also provide other
soluble and contact-dependent signals which promote GC
B cell viability, proliferation, and chemotactic responsive-
ness (4, 13). It has also been asserted that FDCs may be the
“nucleating force” for the initial formation of GCs within
the specific anatomical location they occupy (4).
Lymphotoxin (LT)
 
b 
 
is an immediate member of the TNF
family, first identified by virtue of its ability to anchor LT
 
a
 
(TNF-
 
b
 
) to the surface of T cell hybridomas (14, 15). Both
LT
 
a
 
 and LT
 
b
 
 are now known to be produced by activated
B cells, activated T cells, and NK cells (16, 17). Effects of
LT
 
b
 
R engagement include integrin upregulation (18), cyto-
toxicity (19, 20), and induction of chemokine production
 
(21). Most notably, 
 
lt
 
a
 
2
 
/
 
2
 
 mice, 
 
lt
 
b
 
2
 
/
 
2
 
 mice, and 
 
lt
 
b
 
r
 
2
 
/
 
2
 
mice lack peripheral LNs and Peyer’s patches, and have a
disorganized splenic architecture with almost complete loss
of GCs and FDC networks (22–29). Having said this, most
 
lt
 
b
 
2
 
/
 
2
 
 mice still have mesenteric (M)LNs (26, 27, 30). Fur-
thermore, the MLNs still form GC-like cell clusters in rudi-
mentary B cell follicles despite the apparent lack of FDC net-
works (26, 30). Similar observations have been made in the
spleen of 
 
lt
 
b
 
2
 
/
 
2
 
 mice and 
 
lt
 
b
 
r
 
2
 
/
 
2
 
 mice (27–29), although
these studies also found residual FDC-like cells. Although
not yet proven, the latter may be FDC precursors or imma-
ture FDCs but equally so might represent GC dendritic cells
(GCDCs), which are distinct from FDCs and have so far
been described in human tonsils (31) but not in mice.
 
Therefore, 
 
lt
 
b
 
2
 
/
 
2
 
 mouse MLNs appeared to present a
unique model of in vivo GC reaction in the absence of FDC
networks. Although other studies have suggested that GCs can
form in the absence of antigen trapping on FDCs (32), an
FDC-less mouse model was unprecedented and would further
studies of GC reaction. 
 
Lt
 
b
 
2
 
/
 
2
 
 mice might also facilitate the
identification and evaluation of GCDCs. Finally, knowledge
 
1
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 APC, allophycocyanin; CG, chicken
 
g
 
-globulin; DIG, digoxigenin; FDC, follicular dendritic cell; GC, germinal
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mesenteric lymph node; NP, (4-hydroxy-3-nitrophenyl)acetyl; PNA,
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of the consequences of a lack of FDC networks will also be es-
sential in assessing the potential utility of causing FDC regres-
sion. That is, it was recently reported that administration of
soluble LT
 
b
 
R to adult mice
 
 
 
results in temporary regression of
FDC networks (33). Thus, there is now the prospect of being
able to eliminate FDC networks in circumstances in which
this might be considered likely to yield therapeutic benefit.
For example, loss of FDC networks during triple drug therapy
might eliminate this important HIV reservoir.
With all of this in mind, this study reports the dynamics of
GC reaction and B cell memory formation in 
 
lt
 
b
 
2
 
/
 
2
 
 mice.
Initiation of antigen-specific GCs in the MLNs of 
 
lt
 
b
 
2
 
/
 
2
 
mice was relatively normal, but GC B cell numbers subse-
quently fell dramatically. GC B cells were clustered in the
anatomical locations expected of GCs, indicating that this
process is not critically dependent on FDC networks. 
 
Lt
 
b
 
2
 
/
 
2
 
mice also generated substantial B cell memory despite defec-
tive GC processes, albeit of relatively low affinity. Some an-
tigen-specific antibody affinity maturation did occur and was
even more apparent in the memory response, suggesting that
somatic hypermutation had occurred. This is in agreement
with other studies where somatic hypermutation was evi-
dent, even in the complete absence of GCs (24, 34).
 
Materials and Methods
 
Reagents.
 
The protein G–Sepharose column–purified antibod-
ies anti–
 
l
 
1 L chain (Ls136) and FDC-M2 were provided by Garnett
Kelsoe (Duke University, Durham, NC) and Marie Kosco-Vilbois
(Serono Pharmaceutical Research Institute, Geneva, Switzerland),
respectively. Both were conjugated using a biotin coupling reagent
(Boehringer Mannheim) at a biotin/antibody molar ratio of 10:1 and
purified on a Sephadex G-25 column (Boehringer Mannheim). Rat
anti–mouse IgD and anti–mouse CD11b (Mac-1) from PharMingen
were also coupled as above but with digoxigenin (DIG) rather than
biotin, also from Boehringer Mannheim.
Chicken 
 
g
 
-globulin (CG; Sigma) was conjugated with
(4-hydroxy-3-nitrophenyl)acetyl (NP) succinimide ester (Calbio-
chem) in 0.1 M sodium borate, pH 9.2, to a NP/CG molar ratio
of 13:1 (NP
 
13
 
CG) and then dialyzed against PBS. PE (Molecular
Probes) was haptenated in the same fashion but in the dark at a
molar ratio of 20:1 to generate NP
 
20
 
PE. BSA was also haptenated
to create NP
 
2
 
BSA and NP
 
15
 
BSA. The precise degree of haptena-
tion was not determined.
 
Animals and Animal Challenge. Cd40l
 
2
 
/
 
2
 
 mice and 
 
lt
 
b
 
2
 
/
 
2
 
 mice
are those described previously (26, 35). Wild-type control mice were
derived from original wild-type littermates of 
 
lt
 
b
 
2
 
/
 
2
 
 mice (26).
 
Tcr(
 
b3d
 
)
 
2
 
/
 
2
 
 mice were generated from breeding pairs originally
purchased from The Jackson Laboratory. All mice are on a mixed
background of C57BL/6 and 129/Sv and were housed in specific
pathogen–free conditions. All experiments were conducted in ac-
cordance with Yale University Animal Care and Use guidelines.
Mice at 6–8 wk of age were challenged intraperitoneally with
50 
 
m
 
g of either CG or NP
 
13
 
CG, both of which were adsorbed to
alum in 0.1 ml PBS. Some mice at various times may have re-
ceived a second challenge of 200 
 
m
 
g NP
 
13
 
CG in 0.1 ml PBS alone.
Hyperimmunized mouse serum for the purpose of anti-NP an-
tibody standardization (see below) was obtained from wild-type
mice 6 d after being boosted with 0.2 mg NP
 
13
 
CG in PBS, 27 d af-
ter the primary challenge with 50 
 
m
 
g NP
 
13
 
CG adsorbed to alum.
 
MLN Histology.
 
MLNs were frozen in Tissue-Tek OCT
 
compound (VWR Scientific) using a dry-ice/methylbutane bath
and stored at 
 
2
 
70
 
8
 
C until cutting. Sections of 5-
 
m
 
m thickness
were cut onto silanized glass slides, fixed in cold acetone for 10
min, air-dried, and then stored at 
 
2
 
70
 
8
 
C until use. For staining,
sections were thawed for 30 min and then rehydrated in PBS for
20 min. Endogenous peroxidase was quenched with 0.3% hydro-
gen peroxide for 5 min. Sections were washed in PBS for 10 min
and then preblocked with PBS/3% BSA/0.1% Tween 20 for 30
min in a humidified chamber. Staining for IgD was with rat anti-
IgD (Southern Biotechnology Associates) and then horseradish
peroxidase–conjugated goat anti–rat IgG (Southern Biotechnol-
ogy Associates). The presence of FDCs was assessed with biotin-
conjugated FDC-M2 (see Reagents). Other biotin-conjugated
antibodies were anti-CD23 and anti-CD24, both from PharMin-
gen. All biotin conjugates used a secondary step of alkaline phos-
phatase–conjugated streptavidin (Zymed). Incubations were in a
humidified chamber for 1 h. Washes between steps were with
PBS/0.1% Tween 20. Substrates for horseradish peroxidase and
alkaline phosphatase were diaminobenzidine (brown) and NBT/
BCIP (purple-blue), respectively (Zymed). Counter-staining was
with nuclear fast red (Zymed).
 
MLN Cell Preparation.
 
MLNs were harvested into 0.5 ml
cold digest buffer in a 4-well plate (Nunc) on ice. Digest buffer
was Bruff’s medium with 5% FCS, 0.1 mg/ml collagenase type
IV (Sigma), and 0.1 mg/ml deoxyribonuclease type I (Sigma).
Bruff’s medium is Click’s medium (Irvine Scientific) supple-
mented with 40 mM 
 
l
 
-glutamine, 60 
 
m
 
M 2-ME, 0.7 mM so-
dium bicarbonate, and 58 mg/l gentamycin. The capsule of each
MLN was torn and teased open with 27-gauge needles before
incubating plates at 37
 
8
 
C for 30 min. Capsules were then further
disrupted to release MLN cells by pipetting. The cell suspension was
made up to 10 ml with Bruff’s/5% FCS, filtered through 0.1-mm
nylon mesh (Small Parts, Inc.), and centrifuged at 800 revolu-
tions/min in a bench-top centrifuge at 4
 
8
 
C for 5 min. Finally,
cells were resuspended in 2 ml Bruff’s/5% FCS for fluorocytome-
try or antigen-specific antibody determination as described below.
 
Fluorocytometry.
 
MLN cells were prepared as described above,
and aliquots of 10
 
6
 
 cells were resuspended into 0.2 ml PBS/1%
FCS supplemented with 5 
 
m
 
g/ml FcBlock (PharMingen). Sam-
ples were left on ice for 30 min before primary antibodies were
added, and were then left on ice in the dark for an additional 1 h.
Samples were washed by being made up to 1.2 ml with PBS/1%
FCS before centrifugation at 800 revolutions/min at 4
 
8
 
C for 5
min. Secondary antibody incubation and rewashing were done as
above. Four-color fluorocytometry used a FACSCalibur
 
®
 
 with
argon and helium-neon lasers (Becton Dickinson). Data from 2.5 
 
3
 
10
 
5
 
 events were analyzed with CellQuest software by first gating
on lymphocytes/lymphoblasts, based on forward and side scatter.
PharMingen antibodies used included anti-CD4–allophycocyanin
(APC; L3T4, RM4-5), anti-CD8
 
a
 
–APC (53-6.7), anti-CD90.2–
APC (53-2.1), GL7-FITC, anti-CD45R–FITC, anti-CD24–biotin
(M1/69), and anti-CD45R–biotin. Peanut agglutinin (PNA)-
biotin, streptavidin–Cy-Chrome, and anti-digoxin–Cy5 were
from Vector, PharMingen, and Jackson Laboratories, respec-
tively. Other reagents used were anti-
 
l
 
1–biotin, anti-IgD–DIG,
and anti-CD11b–DIG, described in Reagents above.
 
MLN Antigen-specific Antibody Determination.
 
Antigen-spe-
cific antibody determination was done essentially as described by
Kelly et al. (36), using antibody-secreting cells directly in an
ELISA. Maxisorp 96-well plates (Nunc) were coated at 4
 
8
 
C for
16–20 h with 10 
 
m
 
g/ml NP
 
2
 
BSA or NP
 
15
 
BSA in PBS, 0.1 ml al-
iquot per well. Plates were then washed four times with PBS be-
fore blocking with PBS/1% FCS for 2–3 h. Meanwhile, MLN 
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cells were prepared at 10
 
7
 
 cells per ml of Bruff’s/5% FCS as de-
scribed above. MLN cell aliquots of 0.1 ml were then plated in
wells and cultured at 37
 
8
 
C for 5 h alongside a twofold serial dilu-
tion of serum from a standard hyperimmunized wild-type mouse
(see above; serum dilution was with PBS/1% FCS). Subsequent
washes were with PBS/0.05% Tween 20. Ig detection used iso-
type-specific alkaline phosphatase–conjugated reagents and pNPP
substrate as described (Southern Biotechnology Associates). OD
 
405
 
was determined with a microplate reader (model 550; BioRad).
Typically, a 1:12,800 dilution of hyperimmunized wild-type mouse
serum gave an OD
 
405
 
 of 
 
z
 
2.7 and 1.9 above background for IgG1
detected with NP
 
2
 
BSA and NP
 
15
 
BSA, respectively. The lower limit
of detection was typically at a serum dilution of 1:1,638,400, giving
an OD
 
405
 
 of 
 
z
 
0.05–0.10 above background. The anti-NP–specific
antibody titer of samples was expressed as relative units, representing
the reciprocal of the standard serum dilution giving the same OD
 
405
 
as the sample. Calculations were by four-parameter analysis using
Microplate Manager III software (BioRad).
 
Serum Antigen-specific Antibody Determination.
 
Blood was har-
vested from mice for serum by cardiac puncture at the time of
culling. Maxisorp plates were coated with NP
 
2
 
BSA or NP
 
15
 
BSA,
blocked, and washed as described above. Serum aliquots of 0.1 ml
(1:10
 
5
 
 in PBS/1% FCS) were applied to wells for 1 h alongside a
twofold serial dilution of serum from a hyperimmunized wild-
 
type mouse (see above; serum dilution was with PBS/1% FCS).
Antigen-specific Ig determination then proceeded as described in
the previous section.
 
Results
Ltb2/2 Mice Form GC B Cell Clusters but Lack FDCs.
We showed previously that ltb2/2 mice form PNA-bind-
ing, IgD2B2201 cell clusters in B cell areas of their MLNs
(26, 30), characteristic of GCs (37). Although IgD1 B cells
were also found to infiltrate T cell areas, the GC-like B cell
clusters were within IgD1 B cell follicles at the periphery of
MLNs, as in wild-type mouse MLNs (26, 30). These ob-
servations were extended here by staining for CD24. Pri-
mary follicle B cells are CD241, but GC B cells are CD24hi
(38–40; Fig. 1 A). This also appeared to be true of ltb2/2
GC B cell clusters (Fig. 1 B). Again, the ltb2/2 GC B cells
were clustered within the location expected of wild-type GCs.
Immunohistology with anti–complement receptor 1 (CR-1)
and FDC-M1 suggested that ltb2/2 mice lack FDCs (26).
We subsequently showed that although wild-type mouse
MLNs have very large amounts of IgM immune complex
Figure 1. Ltb2/2 mice gener-
ate GC B cell clusters without
FDCs. MLNs were from unchal-
lenged 6–8-wk-old wild-type
mice (A, C, and E) and ltb2/2
mice (B, D, and F) and show
GCs generated at random times
as a result of environmental anti-
gens. Staining for IgD in all pan-
els is brown. CD24 (A and B),
CD23 (C and D), and FDC-M2
(E and F) are purple-blue. The
intensely colored cells in D
(ltb2/2) are B cells, which are
both IgD1 and CD231. This in-
tense color is not as strong in C
(wild-type), presumably because
the intensely CD23hi FDCs have
“quenched” the color reaction
somewhat. Fluorocytometry did
not reveal any significant differ-
ence in CD23 levels between
wild-type and ltb2/2 MLN cells
(data not shown). Original mag-
nification: 362.5.858 Germinal Centers Form without Follicular Dendritic Cells
on FDCs, ltb2/2 mouse MLNs did not have any such de-
posits (30). However, despite all of the above, it is possible
that Ig Fc receptor–bearing (FcR1) FDCs (3, 4, 9) consti-
tute a distinct subset of FDCs which are negative for both
FDC-M1 and CR-1. It is also conceivable that antigen–Ig
complexes retained on such FcR1 FDCs may support GC
reaction in the absence of CR-11 FDCs. In potential sup-
port of this, mice deficient in CR-1 still possess GCs (41,
42), albeit somewhat smaller than wild-type.
Therefore, an evaluation was made as to whether or not
ltb2/2 mice possess FcR1 FDC networks by staining for
CD23 (43). This revealed that ltb2/2 mice completely lack
FcR1 FDC networks (Fig. 1 D), and that the ltb2/2 GC B
cell clusters were CD232 compared with the surrounding
follicle B cells, as expected of wild-type GC B cells (9; Fig.
1 C). FDC networks clearly stained very strongly for CD23
in wild-type mouse MLNs (Fig. 1 C), and were observed
in every B cell follicle regardless of whether or not there
was an ongoing GC reaction. Some discrete CD23lo cells
were seen in the ltb2/2 mouse MLN CD232IgD2 GC cell
clusters (Fig. 1 D). These cells most likely represent GC B
cells that have not yet fully downregulated CD23, but it is
conceivable that they represent immature FDCs or the
mouse equivalent of GCDCs (31).
Finally, the lack of staining by FDC-M2 further empha-
sized the complete absence of FDC networks in the MLNs
of ltb2/2 mice (Fig. 1 F). Although FDC-M2 has not been
fully characterized, it is a useful marker of FDC networks
(Fig. 1 E). Like CD23, FDC-M2 staining was observed in
every wild-type mouse MLN B cell follicle regardless of
whether or not there was an ongoing GC reaction (data
not shown). As with CD23, a low level of FDC-M2 stain-
ing may well mark immature FDCs or another cell type
such as the mouse equivalent of GCDCs (31). Neither im-
mature FDCs nor mouse GCDCs have yet been defined.
Ltb2/2 Mice Show Increased GC B Cells upon Intraperito-
neal Challenge. Four-color fluorocytometry was adopted
in order to study further the GC reaction in ltb2/2 mouse
MLNs (see Materials and Methods). Most non-GC B cells
were excluded as “lineage”-positive (Lin1) cells, using a
combination of antibodies against CD4, CD8a, CD90.2,
IgD, and CD11b (Fig. 2). Markers to discriminate GC B
cells included PNA binding (37, 38), anti-CD24 (38–40),
and GL7 (44). PNA binding and CD24 are increased on
GC B cells, whereas GL7 recognizes an activation antigen
found on GC B cells but not naive or memory B cells. Flu-
orocytometry of MLNs is simple compared with spleen
due to the relative lack of immature B cells, granuloid cells,
and erythroid cells. After excluding nonlymphoid particles
of low forward scatter (data not shown), most Lin2 cells in
MLNs are PNAhiCD24hi (data not shown). This is demon-
strated in Fig. 2 with MLNs 12 d after intraperitoneal chal-
lenge with CG adsorbed to alum.
As expected, both T cell–less mice and cd40l2/2 mice fail
to generate GC B cells (Fig. 2), most clearly demonstrated
with GL7. Both wild-type mice and ltb2/2 mice revealed
substantial levels of Lin2GL71 cells in their MLNs, al-
though ltb2/2 mice consistently had lower levels than
wild-type mice (see also below). Lin2GL71 cells repre-
sented about half of all Lin2PNAhiCD24hi cells (Fig. 2) and
were CD45R1 (data not shown; see below). Lin2 cells in-
clude non-GC B cells such as antibody-secreting cells and
memory B cells, which would be GL72.
The levels of Lin2GL71 GC B cells at day 12 after chal-
lenge (Fig. 2) were much higher than those in unchal-
lenged mice, and were similar to those observed in the
spleen with the same antigenic challenge (45). Without in-
traperitoneal challenge, the levels of Lin2GL71 cells were
0.3–0.7% of total MLN cells in both wild-type mice and
ltb2/2 mice (data not shown; see below), consistent with
levels in the spleen of unchallenged wild-type mice (45).
Thus, intraperitoneal challenge in alum is an effective
means of inducing GC B cell generation in the MLNs of
both wild-type mice and ltb2/2 mice.
Ltb2/2 Mice Generate Antigen-specific GC B Cells. The
hapten NP has been used extensively in GC studies (40, 45–
48). The primary response to NP is dominated by antibodies
bearing a l1 light chain, recognized by the antiidiotype anti-
body Ls136 (39, 49–52). NP-specific antibody-bearing cells
can also be followed by their capacity to bind NP-conjugated
PE (NP20PE). NP also provides a means for evaluating anti-
NP–specific antibody affinity maturation (described below).
Figure 2. Fluorocytometry reveals GC B
cells in ltb2/2 mouse MLNs. Most non-GC
B cells were excluded as Lin1 cells (see text).
GC B cells were further identified with
PNA, CD24, and GL7. Plots shown are a
representative experiment using MLN 12 d
after intraperitoneal challenge with 50 mg
CG adsorbed to alum. The boxed areas in-
clude GC B cells, and the numbers along-
side them indicate the percentage of the to-
tal MLN cells therein. WT, wild-type.859 Koni and Flavell
Mice were challenged intraperitoneally with either CG
or NP-haptenated CG (NP13CG), and MLNs were ex-
amined for NP-specific response 8 d later. Both wild-
type mice and ltb2/2 mice showed massive numbers of l11
NP20PE-binding MLN cells in response to NP13CG
(Fig.  3). The percentage of CD45R1 cells that were l11
NP20PE-binding were 66.1 6 18.2 and 76.6 6 17.2 for
wild-type mouse MLNs and ltb2/2 mouse MLNs, respec-
tively (n 5 6 each), compared with ,0.1% in unchallenged
mice. As expected (46), CG itself did not elicit any signifi-
cant levels of l11 NP20PE-binding cells (data not shown).
Also, T cell–less mice and cd40l2/2 mice did not show sig-
nificant levels of l11 NP20PE-binding cells (Fig. 3).
NP-specific GC B cells were also evident in MLNs from
both wild-type mice and ltb2/2 mice at day 8 after chal-
lenge (Fig. 4), defined as the Lin2GL71 subset (see Fig. 2).
Both the fraction of ltb2/2 GC B cells that were NP20PE-
binding and the intensity of NP20PE-binding appeared to
be relatively normal (Fig. 4). The response of wild-type
mice and ltb2/2 mice was then followed from day 8 to day
24 after challenge (Fig. 5). As early as day 12 after chal-
lenge, ltb2/2 mouse MLN l11 GC B cells were greatly
reduced compared with wild-type, and even fewer were
NP20PE-binders (Fig. 5). Having said this, the rate of de-
cline of ltb2/2 GC B cells was not sustained at day 16 after
challenge. Instead, Lin2GL71l11 ltb2/2 GC B cell levels
appeared to plateau such that they were comparable to
wild-type at day 20 after challenge before then falling again
by day 24 (Fig. 5). This pattern was reflected among
Lin2GL72l11 non-GC cells.
Ltb2/2 Mice Generate Antigen-specific Memory B Cells. Both
ltb2/2 mice and wild-type mice showed anti-NP antibody se-
cretion among MLN cells at day 6 after challenge with 50 mg
NP13CG adsorbed to alum (Fig. 6). IgA and IgG2a were not
detected at all (data not shown). Clearly, IgG1 secretion by
ltb2/2 mouse MLN cells (average relative units 5 0.91) was
much lower than wild-type (average 5 6.03), perhaps indicat-
ing a lack of T cell and/or dendritic cell help. Nonetheless, this
level of IgG1 secretion by ltb2/2 mouse MLNs was z20-fold
higher than the lower limit of detection. Also, a primary chal-
lenge with 0.2 mg NP13CG in PBS alone did not result in sig-
nificant anti-NP antibody secretion by either wild-type or
ltb2/2 mouse MLN cells at day 6 after challenge (data not
shown). Thus, the response to NP13CG in PBS was a good in-
dicator of memory generated as a result of primary challenge
with NP13CG adsorbed to alum (see below).
To determine whether or not humoral memory was
generated, mice were challenged as before and then rechal-
lenged at various times with either 0.2 mg NP13CG in PBS
without alum or PBS alone. 6 d later, anti-NP antibody
was determined among MLN cells and in serum. Both the
level of anti-NP antibody and the relative affinity for NP
were determined by ELISA using two different BSA sub-
strates. Total and relatively high affinity anti-NP antibody
were determined with densely (NP15BSA) and sparsely
(NP2BSA) haptenated BSA, respectively. As GC reaction
proceeds, a greater proportion of anti-NP antibody becomes
detectable with NP2BSA. The principal of this approach has
been used in several other studies (24, 26, 34), and was re-
cently validated with mAbs of various affinity for NP (45).
When given a secondary challenge and harvested at week
4, ltb2/2 mouse MLNs appeared to secrete more anti-NP
antibody than wild-type mouse MLNs (Fig. 7), implying
that ltb2/2 mice had generated greater humoral memory
than wild-type mice. This pattern was not so apparent in se-
rum (Fig. 7). Nonetheless, ltb2/2 mice clearly showed mem-
ory even in their serum. The substantial memory response
was still evident among ltb2/2 mouse MLNs at week 10 af-
ter challenge but was less evident in serum (Fig. 7).
Both wild-type mouse MLNs and ltb2/2 mouse MLNs
showed affinity maturation in the post-GC phase between
weeks 4 and 10 after challenge (Fig. 7). Thus, the relatively
low NP2/NP15 ratio in ltb2/2 mouse MLNs at week 4 after
challenge was almost normal at week 10. Again, this obser-
vation in MLNs was not obvious in serum (Fig. 7). At both
weeks 4 and 10 after challenge, ltb2/2 mice showed a
lower NP2/NP15 ratio in their serum than wild-type mice,
indicating a defect in GC affinity maturation processes.
Figure 3. Ltb2/2 mice show antigen-
specific B cell expansion in their MLNs.
MLNs were harvested at day 8 after chal-
lenge with 50 mg NP13CG adsorbed to
alum, and cells were examined for NP20PE-
binding and surface l1 antibody chain. WT,
wild-type.
Figure 4. Ltb2/2 mice generate antigen-specific GC B cells. Plots
show NP20PE-binding and surface l1 antibody chain among Lin2GL71
GC B cells from wild-type mouse MLNs (top) and ltb2/2 mouse MLNs
(bottom) at day 8 after challenge with 50 mg NP13CG adsorbed to alum.860 Germinal Centers Form without Follicular Dendritic Cells
Discussion
Numerous lines of evidence have now shown that ltb2/2
mice do not have FDC networks (26, 27, 30, and this
study). In addition, MacKay and Browning (33) have very
recently shown that administration of soluble LTbR to
adult mice causes regression of FDC networks and dissipa-
tion of the antigen they were retaining. Clearly however,
ltb2/2 mice might still have FDC precursors. Indeed, irra-
diated adult lta2/2 mice generate mature FDC networks of
lta2/2 origin upon reconstitution with wild-type bone
marrow (53), and equivalent results have been obtained
with ltb2/2 mice (data not shown). The location of FDC
precursors in ltb2/2 mice is at present unknown, and it is
conceivable that they will be found within B cell follicles
and GCs even though they fail to develop into mature
FDC networks. Others have shown that ltb2/2 mice and
ltbr2/2 mice do have small numbers of discrete FDC-M21
cells in the spleen (27, 28), leading to the suggestion that
these cells may represent FDC precursors or immature
FDCs. However, there is no evidence that FDC-M2 is com-
pletely specific to FDCs, although it is a useful marker of
FDC networks. Unlike FDC-M2, FDC-M1 has been well
characterized and is considered to be relatively FDC specific,
but even this marker also stains tingible body macrophages
(which are found in GCs) and some endothelial cells (54).
The origin of FDCs is somewhat controversial (for a re-
view, see reference 55) and will undoubtedly be further
complicated by the fact that mice may also prove to have
GCDCs (31), which might be the FDC-M21 cells seen by
others. Regardless of whether or not ltb2/2 mice have
FDC precursors, the roles FDCs are said to fulfill largely
rely on the extensive dendritic processes of FDC networks.
Clearly, these structures are absent.
The absence of FDC networks presumably has indirect
as well as direct effects on GC reactions. For example, this
study has not considered GC T cells in ltb2/2 mice. Other
defects clearly exist in ltb2/2 mouse MLNs, such as the B
cell infiltration of the T cell areas and reduced primary hu-
moral response. What this study has attempted to do is
highlight the processes that occur despite the defects. Most
notably, ltb2/2 mice generate antigen-specific GC B cells
and class-switched memory B cell responses. Having said
this, antigen-specific ltb2/2 GC B cells decline rapidly at
times when wild-type GC B cell numbers are still relatively
high. GCs normally have a life span of a few weeks (10,
56). It has been argued that the regression of GCs begins at
a time when FDCs begin to bury their retained antigen
within membrane pockets, thereby ceasing to present anti-
gen to GC B cells (56). The decline of ltb2/2 GC B cells in
the absence of FDC networks may be a premature execu-
tion of this process. On the other hand, ltb2/2 GC B cell
numbers did not decline further between days 12 and 16
after challenge but instead appeared to plateau until they fi-
nally decreased further between days 20 and 24. It is con-
ceivable that the Lin2GL71l11 cell numbers were main-
tained by further generation of such cells from centroblasts.
Anti-NP memory and relative affinity maturation were
assessed at various times. The humoral memory response in
ltb2/2 mouse MLNs was as great if not greater than that
seen in wild-type mouse MLNs (Fig. 7). Of course, this
Figure 5. Ltb2/2 GC and non-
GC antigen-specific MLN cells
decline rapidly. MLNs were har-
vested at various times after chal-
lenge with 50 mg NP13CG
adsorbed to alum. Antigen-specific
GC and non-GC cells were
defined as Lin2GL71l11 and
Lin2GL72l11 cells, respectively.
Wild-type mouse MLN cells (cir-
cles) and ltb2/2 mouse MLN cells
(triangles) are shown as both total
Lin2l11 cells (filled symbols) and
as cells therein that also bound
NP20PE (open symbols). 4–6 mice
were used per group and are repre-
sented as the average plus SD (8 of
38 ltb2/2 mice used for this study
did not appear to have MLNs).
Figure 6. Ltb2/2 mice generate reduced but significant antigen-spe-
cific antibody in their MLNs. MLNs were harvested from six wild-type
mice (circles) and ltb2/2 mice (triangles) at day 6 after challenge with 50 mg
NP13CG adsorbed to alum and were assayed for IgM (open symbols) and
IgG1 (filled symbols) using NP15BSA as the detection substrate. Data are
shown as relative units using IgG1 detection in the serum of a hyperim-
munized wild-type mouse as a standard (see Materials and Methods).861 Koni and Flavell
Figure 7. Ltb2/2 mice generate humoral memory and show post-GC affinity maturation. Mice were harvested at both week 4 and week 10 after chal-
lenge with 50 mg NP13CG adsorbed to alum. Anti-NP antibody levels were followed in MLNs (top two rows) and serum (bottom two rows) using five
to seven wild-type mice (circles) and ltb2/2 mice (triangles) per group. Some groups were given a secondary challenge of 0.2 mg NP13CG in PBS alone
6 d before culling (filled symbols), while others were given just PBS (open symbols). Data are shown for both NP2BSA and NP15BSA as detection sub-
strate (8 of 32 ltb2/2 mice used for this study did not appear to have MLNs). Anti-NP IgG1 relative units (31025) represent the reciprocal of the standard
serum dilution giving the same OD405 as the sample. Note that the MLN anti-NP IgG1 assays are not directly comparable with the serum assays. Also
shown are the resultant NP2/NP15 ratios of the memory responses (filled symbols), which are a reflection of relative anti-NP affinity. Numbers alongside
various data points indicate overlapping mice, and bars represent averages.862 Germinal Centers Form without Follicular Dendritic Cells
may not be a direct reflection of the actual frequency of
NP-specific memory B cells. The relatively low level of
NP-specific non-GC B cells (Lin2l11 NP20PE-binding) in
ltb2/2 mouse MLNs late in the GC phase (Fig. 5) suggests
that ltb2/2 mouse MLNs produce significantly fewer mem-
ory B cells than wild-type mouse MLNs.
The degree of affinity maturation observed in serum
here was similar to that previously reported for lta2/2
mice, Lyn kinase (lyn)2/2 mice, and ltb2/2 mice (24, 26,
34). Affinity maturation requires somatic hypermutation
and subsequent selection of higher affinity clones, suggest-
ing that specific activated B cells had entered into a “GC B
cell program” despite the complete absence of GCs in lta2/2
mice and lyn2/2 mice. Indeed, somatic hypermutation is
evident in lta2/2 mice and lyn2/2 mice (24, 34), and there
is no reason to believe that this is not occurring in ltb2/2
mice. Certainly, somatic hypermutation is normally evi-
dent as early as day 7 after challenge (40, 45, 48, 57, 58)
and, unlike lta2/2 mice (24) and lyn2/2 mice (34), ltb2/2
mice generate appreciable levels of antigen-specific GC B
cells upon challenge (this study).
Where and how are high-affinity mutants selected in the
absence of GCs? Takahashi et al. (45) recently described
evidence in support of a phenomenon best described as
“post-GC intraclonal competition.” The average affinity of
anti-NP antibody from bone marrow antibody-secreting
cells continued to increased long after the GC reaction had
waned (45). Although clonal selection occurs indepen-
dently in each GC and low-affinity B cells can survive the
selection process within GCs if high-affinity competitors
are absent (45), post-GC affinity-driven selection processes
effectively constitute “inter-GC selection.” This concept is
supported by the study here, where the relative affinity of
anti-NP antibody at week 10 after challenge was about
twofold higher than that at week 4 after challenge (Fig. 7),
in the MLNs of wild-type mice and ltb2/2 mice.
Thus, mutants with higher affinity for the antigen are
generated and selected even in ltb2/2 mice, but the highest
possible affinity for antigen is not achieved in ltb2/2 mice
(Fig. 7), presumably because further rounds of somatic mu-
tation cannot occur in the post-GC phase. Hence, despite
post-GC intraclonal competition, the benefit of the GCs is
as an environment in which repeated rounds of somatic
mutation and selection can occur rapidly in order to
achieve the highest possible affinity for antigen. Indeed, al-
though substantial somatic hypermutation was observed in
lta2/2 mice, the degree of mutation among V186.2 genes
was only about half that seen in wild-type mice (24).
It should also be borne in mind that the apparent degree
of affinity maturation by post-GC intraclonal competition
will vary substantially depending on the nature of the anti-
gen. In some experimental instances, random mutations lead
to higher affinity clones at a relatively high frequency (59).
The NP hapten used here and by others (24, 34, 45) would
appear to be another such example, since a frequently occur-
ring single point mutation in the V186.2 gene (24, 60) is as-
sociated with greatly increased affinity for NP (61). Thus, the
studies here showing defective NP-specific affinity matura-
tion in ltb2/2 mice can only be interpreted to suggest that
affinity maturation within GCs has failed in these mice.
Recirculating memory B cells migrate between secondary
lymphoid organ follicles where they can respond to antigen
held on FDC networks (62, 63). Marginal zone memory B
cells are said to be long-lived and non-recirculating (64–66),
and it is difficult to conceive of how their maintenance could
be dependent on antigen retained by FDC networks. As the
name suggests, marginal zone memory B cells have been best
characterized in the marginal zone of the spleen, where they
are seen to appear both immediately before and during GC
reactions (63–65). Equivalent areas are located on the inner
wall of the subcapsular sinus of LNs, and may be substantial
in MLNs (65). Further studies will be necessary to character-
ize the B cell memory in ltb2/2 mice, including how the na-
ture and dose of antigen might affect memory maintenance
besides memory generation per se.
In conclusion, this study has considered GC reactions in
the MLNs of ltb2/2 mice and found that both GC and B
cell memory are formed despite the complete absence of
FDC networks. However, antigen-specific antibody affin-
ity maturation is defective. This study of the MLNs of ltb2/2
mice serves as a model for the consequences of administra-
tion of soluble LTbR with respect to LNs. The spleen of
ltb2/2 mice was not studied here because it is more disor-
ganized than the MLNs (26, 27, 30). The fact that anti-NP
memory at week 10 was much less apparent in serum than
in MLNs (Fig. 7) may well be a reflection of the fact that
serum antibody levels are dominated by the spleen and
spleen-derived bone marrow antibody-secreting cells. Hav-
ing said this, even the spleen of ltb2/2 mice generates some
PNA-binding GC-like B cells (27).
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